MYRIAD GENETICS, INC. Investments and Cash
MYRIAD GENETICS, INC. (MYGN) had Investments and Cash of $97.30 million as of 2024-06-30, per its 10-Q filed 2024-08-07.
Financial Statements › Balance Sheet › Assets
us-gaap:InvestmentsAndCash · last filed 2025-02-28
- 2024-06-30: Investments and Cash $97.30M.
- 2024-03-31: Investments and Cash $104.30M.
- 2023-12-31: Investments and Cash $140.90M.
- 2023-09-30: Investments and Cash $86.30M.
| Period end | Investments and Cash | Investments and Cash as first filed |
|---|---|---|
| 2024-06-30 | $97.30M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $104.30M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $140.90M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $86.30M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $127.80M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $109.10M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $169.70M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $259.20M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $283.60M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $339.20M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $397.80M 10-K · filed 2023-03-01 | $398.80M 10-K · filed 2022-02-25 |
| 2021-09-30 | $413.60M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $184.30M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $188.00M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $171.70M 10-K · filed 2022-02-25 | |
| 2020-09-30 | $190.60M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $254.80M 10-KT · filed 2021-03-16 | $253.50M 10-K · filed 2020-08-13 |
| 2020-03-31 | $223.80M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $188.60M 10-Q · filed 2020-02-07 | |
| 2019-09-30 | $193.50M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $191.80M 10-KT · filed 2021-03-16 | $191.20M 10-K · filed 2019-08-13 |
| 2019-03-31 | $189.90M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $195.60M 10-Q · filed 2019-02-06 | |
| 2018-09-30 | $192.10M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $211.90M 10-K · filed 2019-08-13 | |
| 2018-03-31 | $209.20M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $202.40M 10-Q · filed 2018-02-07 | |
| 2017-09-30 | $198.40M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $199.30M 10-K · filed 2018-08-24 | |
| 2017-03-31 | $225.60M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $218.30M 10-Q · filed 2017-02-08 | |
| 2016-09-30 | $200.40M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $238.40M 10-K · filed 2017-08-09 | |
| 2016-03-31 | $286.10M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $285.60M 10-Q · filed 2016-02-03 | |
| 2015-09-30 | $198.30M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $185.40M 10-K · filed 2016-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |